Insmed Inc (INSM)vsShattuck Labs Inc (STTK)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
STTK
Shattuck Labs Inc
$6.37
+4.08%
HEALTHCARE · Cap: $445.13M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 60542% more annual revenue ($606.42M vs $1.00M). STTK leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
STTK
Avoid19
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -60.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : STTK
STTK has a balanced fundamental profile.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : STTK
The primary concerns for STTK are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while STTK is a value play — different risk/reward profiles.
STTK carries more volatility with a beta of 1.67 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
STTK generates stronger free cash flow (-8M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 19/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Shattuck Labs Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. The company is headquartered in Austin, Texas.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?